Pillar, LC-SCRUM-Asia, LSI Medience partner on liquid biopsy screening

Aug. 19, 2026—Pillar Biosciences, LC-SCRUM-Asia, and LSI Medience Corp. are collaborating to support the genomic screening of blood-based samples from patients with lung cancer as part of the LC-SCRUM-Asia project in Japan.